Volv has developed surveillance capabilities to red flag patients at an anonymised, aggregate level.

As we roll out globally, we can consolidate these views to give insights in different geographies. Generating an aggregate view of how disease can be spotted and treated, can lead to the creation of different patient pathways.

From each added data set we can generate more valuable insights into the disease and patient journeys with inSight and the Patient journey explorer